Novel Therapies Transform the Amyloidosis Treatment Market

adicionou um novo artigo Health

2026-09-24 05:53:53 - Traduzir -

The amyloidosis treatment landscape has been transformed by the emergence of novel therapies that target the underlying mechanisms of the disease. For ATTR amyloidosis, therapies such as tafamidis (a stabiliser of transthyretin), patisiran and inotersen (RNA-targeted therapies), and acoramidis are offering new options for patients. For AL amyloidosis, advances in chemotherapy and monoclonal...

0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior